Get Real Time Here
| Open13.720 | Close14.260 |
| Vol / Avg.143.026K / 365.971K | Mkt Cap490.490M |
| Day Range13.500 - 14.490 | 52 Wk Range10.470 - 31.450 |
RAPT Therapeutics Stock (NASDAQ:RAPT), Quotes and News Summary
RAPT Therapeutics Stock (NASDAQ: RAPT) stock price, news, charts, stock research, profile.
| Open13.720 | Close14.260 |
| Vol / Avg.143.026K / 365.971K | Mkt Cap490.490M |
| Day Range13.500 - 14.490 | 52 Wk Range10.470 - 31.450 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.750 | -0.820 | -0.0700 | ||||
| REV | 0 |
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.800 | -0.660 | 0.1400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-15 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 41.00 |
| 2023-09-14 | Berenberg | Andy Chen | Initiates Coverage On | Buy | Announces | - | 34.00 |
| 2023-08-16 | JP Morgan | Anupam Rama | Maintains | OverweightOverweight | Lowers | 39.00 | 32.00 |
| 2023-08-14 | Piper Sandler | Edward Tenthoff | Maintains | OverweightOverweight | Raises | 28.00 | 31.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| RAPT | RAPT Therapeutics | 3.11% | 490.5M |
| MGNX | Macrogenics | -3.4% | 458.4M |
| SPRY | ARS Pharmaceuticals | -5.77% | 423.3M |
| RNA | Avidity Biosciences | 14.61% | 523.2M |
| BLUE | bluebird bio | -0.26% | 418.8M |
How do I buy RAPT Therapeutics (RAPT) stock?
You can purchase shares of RAPT Therapeutics (NASDAQ: RAPT) through any online brokerage.
Who are RAPT Therapeutics's (RAPT) competitors?
Other companies in RAPT Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Avidity Biosciences (NASDAQ:RNA), bluebird bio (NASDAQ:BLUE) and 4D Molecular Therapeutics (NASDAQ:FDMT).
What is the target price for RAPT Therapeutics (RAPT) stock?
The latest price target for RAPT Therapeutics (NASDAQ: RAPT) was reported by HC Wainwright & Co. on Wednesday, November 15, 2023. The analyst firm set a price target for 41.00 expecting RAPT to rise to within 12 months (a possible 187.52% upside). 18 analyst firms have reported ratings in the last year.
Current Stock Price for RAPT Therapeutics (RAPT)?
The stock price for RAPT Therapeutics (NASDAQ: RAPT) is $14.26 last updated November 28, 2023 at 9:00 PM UTC.
Does RAPT Therapeutics (RAPT) pay a dividend?
There is no dividend information for RAPT Therapeutics.
When is RAPT Therapeutics (NASDAQ:RAPT) reporting earnings?
RAPT Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is RAPT Therapeutics (RAPT) going to split?
There is no upcoming split for RAPT Therapeutics.
What sector and industry does RAPT Therapeutics (RAPT) operate in?
RAPT Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.